Transient loss of HGV induced by interferon treatment does non modify the response of HCV in chronic hepatitis C.

被引：0
|
作者：
Benetti, G
Ramella, G
Tagger, A
Ribero, ML
Merlini, R
Lazza, M
Fasola, M
Portera, G
机构：
[1] Melegnano Hosp, Milan, Italy
[2] Univ Milan, Milan, Italy
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1860
引用
收藏
页码：625A / 625A
页数：1
相关论文
共 50 条
  • [21] HGV infection in 50 patients with non-B non-C hepatitis and 228 patients with chronic hepatitis C.
    Levy, S
    MartinotPeignoux, M
    MartinsAmado, V
    Degott, C
    Erlinger, S
    Marcellin, P
    HEPATOLOGY, 1997, 26 (04) : 1682 - 1682
  • [22] Does interferon-induced hypertriglyceridemia cause apparent non-response of ALT in chronic hepatitis C?
    Lebovics, E
    Sachdeva, N
    Kapur, S
    Antonecchia, P
    Dworkin, BM
    Casellas, A
    Clark, S
    Rosenthal, WS
    GASTROENTEROLOGY, 1996, 110 (04) : A1248 - A1248
  • [23] Cost-effectiveness of interferon treatment for chronic hepatitis C.
    Kareemi, M
    Peltekian, KM
    HEPATOLOGY, 1996, 24 (04) : 597 - 597
  • [24] Interferon and glycyrrhizin combined therapy in the treatment of chronic hepatitis C.
    Naito, M
    Kashiwagi, T
    Tsutsumi, H
    Nagasawa, M
    Toyama, T
    Tanaka, Y
    Ito, A
    Ozaki, S
    Ishibashi, K
    Azuma, M
    HEPATOLOGY, 1996, 23 (01) : P189 - P189
  • [25] Body weight and the response to treatment with interferon in patients with hepatitis C.
    Matta, E
    GASTROENTEROLOGY, 2002, 122 (04) : A305 - A305
  • [26] Hepatitis G infection in patients undergoing interferon treatment for chronic hepatitis C.
    Brandhagen, DJ
    Poterucha, JJ
    Gross, JB
    Kim, WR
    Perez, RG
    Germer, JJ
    Gossard, AA
    Detmer, J
    Kolberg, J
    Collins, M
    Persing, DH
    GASTROENTEROLOGY, 1997, 112 (04) : A1230 - A1230
  • [27] HCV induced hypobetalipoproteinememia: A possible mechanism for steatosis in chronic hepatitis C.
    Serfaty, LD
    Andreani, T
    Chazouilleres, O
    Giral, P
    Delamare, C
    Wendum, D
    Poupon, RY
    HEPATOLOGY, 1999, 30 (04) : 606A - 606A
  • [28] Escalating the dose of interferon does not increase the incidence of virologic response (VR) in patients with chronic hepatitis C.
    Sterling, RK
    Post, AB
    Murphy, MB
    Hoffman, RD
    Jacobs, GH
    GASTROENTEROLOGY, 1997, 112 (04) : A1389 - A1389
  • [29] Efficacy of retreatment with interferon for chronic hepatitis C patients showing transient response in initial treatment
    Iyoda, K
    Yuki, N
    Kato, M
    Komori, M
    Fujii, E
    Sugiyasu, Y
    Nishimura, Y
    Michida, T
    Kaneko, A
    Yamamoto, K
    Kurosawa, K
    Ikeda, M
    GASTROENTEROLOGY, 1999, 116 (04) : A1225 - A1225
  • [30] The effect of HLA haplotype on interferon response in patients with chronic hepatitis C.
    Brandhagen, DJ
    Poterucha, JJ
    Gross, JB
    Gossard, AA
    Therneau, TM
    Persing, DH
    GASTROENTEROLOGY, 1996, 110 (04) : A1157 - A1157
12345